Pending Patents

All patent applications are initially filed as a U.S. Provisional Patent Application and then one year later they are converted to an International Application before they are filed in individual countries.  Only the most recent filing for any application is shown.

  • Altman, E., Fuller, M., Alsaif, G., Smith, S., Maynard, K., Farone, A., Cannabinoid compositions and methods of using, U.S. Provisional Patent Application 62/840,972, Filed on April 30, 2019.
  • Dunlap, N., Newsome, A., Stubblefield, J.M., Pathiranage, A. Anti-trypanosomal compounds and methods, International Application No. PCT/US2016/040112, Filed on June 29, 2016. 
  • Farone, M.B., Handy, S., McClelland, E., Sutton, C., Taylor, Z.E., Aurones as antifungal agents, U.S. Provisional Patent Application 62/351,755, Filed on June 17, 2016.
  • Gao, Y., Altman, E., Cis- and trans-suffruticosol D as therapeutic agents, International Application No. PCT/US2016/044534, Filed on June 28, 2016.
  • Gao, Y., Altman, E., 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione as a cancer therapeutic, International Application No. PCT/US2015/064785, Filed on December 9, 2015.
  • Gao, Y., Altman, E., Farone, A., Park, H., Cis-gnetin H and trans-gnetin H as therapeutic agents, International Application No. PCT/US2015/051424, Filed on September 22, 2015. 
  • Kong, Y., Yang, D., Taylor, Z. E., Handy, S., Altman, E., Aurones and methods of using aurones to treat tuberculosis, U.S. Provisional Patent Application 62/840,788, Filed on April 30, 2019. 
  • Stubblefield, J.M., Taylor, Z.E., Handy, S., Aurones as antitrypanosomal agents, U.S. Provisional Patent Application 62/321,519, Filed on April 12, 2016.
  • Stubblefield, J., Taylor, Z., Handy, S., Farone, M., McClelland, E., Sutton, C., Farone, A., Park, H., Araujo, D., Newsome, A., Therapeutic aurones, International Application No. PCT/US2017/027038, Filed on April 11, 2017.
  • Wright, S. M., Altman, E., Smith, S., Maynard, K., Compositions including ginsenoside 20(S)-Rg3 and methods of using ginsenoside 20(S)-Rg3 to inhibit an alpha herpesvirus, U.S. Provisional Patent Application 62/858,420, Filed on June 7, 2019.